Evidence map›Paper›PMID 31786637›Full record

ArticleCurrent microbiology2020

Impact of Spray-Drying on Biological Properties of Chitosan Matrices Supplemented with Antioxidant Fungal Extracts for Wine Applications.

Elodie Choque, Vanessa Durrieu, Isabelle Alric, José Raynal, Florence Mathieu

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Profiling of Essential Oils from the Leaves ofMolecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Elodie ChoqueLaboratoire de Génie Chimique, Université de Toulouse, CNRS, INPT, UPS, Toulouse, France.
Vanessa DurrieuLaboratoire de Chimie Agro-Industrielle (LCA), Université de Toulouse, INRA, INPT, Toulouse, France. vanessa.durrieu@ensiacet.fr.ORCID http://orcid.org/0000-0003-2731-7748
Isabelle AlricLaboratoire de Chimie Agro-Industrielle (LCA), Université de Toulouse, INRA, INPT, Toulouse, France.
José RaynalLaboratoire de Génie Chimique, Université de Toulouse, CNRS, INPT, UPS, Toulouse, France.
Florence MathieuLaboratoire de Génie Chimique, Université de Toulouse, CNRS, INPT, UPS, Toulouse, France.
Centre National de la Recherche Scientifique · FRInstitut National Polytechnique de Toulouse · FRUniversité Fédérale de Toulouse Midi-Pyrénées · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Black aspergilli produce many bioactive compounds: enzymes, organic acids, and secondary metabolites. One such fungus, Aspergillus tubingensis G131, isolated from French Mediterranean vineyards, produces secondary metabolites with antioxidant properties that can be extracted with ethanol. In this study, crude antioxidant extracts obtained from A. tubingensis G131 cultures were encapsulated with two types of chitosan matrix. Spray-drying was used to obtain dried particles from a dispersion of fungal crude extracts in a solution of the coating agent chitosan. This process appeared to be an efficient method for obtaining a dry extract with antioxidant activity. Three types of fungal extracts, with different antioxidant capacities, were produced: two different concentrations of crude extract and a semi-purified extract. In this study, the chitosan matrices for encapsulation were chosen on the basis of their antimicrobial activities for wine applications. Classical low molecular weight chitosan was compared with NoBrett Inside

Indexed as

Anti-Infective AgentsAntioxidantsAspergillusChitosanDesiccationFungiSecondary MetabolismWineAnti-Infective AgentsAntioxidantsChitosanAntioxidantChitosanFungal metabolitesMicroencapsulationSpray-drying

Identifiers

PMID31786637
OpenAlexW2949744600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.